More on NVDA's investments in other companies including SOUN:
Nvidia Owns These 4 Stocks. Heres How Theyre Doing. -- Barrons.com
11:37 AM ET 6/8/24 | Dow Jones
Angela Palumbo
Nvidia has been one of the best-performing stocks on Wall Street since 2023, amassing holdings in four companies along the way. So, how have these stocks been doing?
First, a bit of context. Nvidia stock has surged 144% in 2024 and 212% over the last 12 months as investors snapped up shares of the chip making company, whose products are used to power artificial intelligence. In May, Nvidia reported much stronger first-quarter earnings and revenue than Wall Street expected -- and the stock has climbed 27% since then.
According to Nvidia's most recent 13F form filed with the Securities and Exchange Commission, as of March 31, 2024, Nvidia has stakes in four publicly traded companies: Arm Holdings, Nano-X Imaging, Recursion Pharmaceuticals, and SoundHound.
Nvidia declined to comment to Barron's on its holdings.
Nvidia's second largest stake is in Arm Holdings, a U.K.-based chip maker with a $143 billion market capitalization. American depositary receipts of Arm have jumped 82% this year, as semiconductor stocks continue to benefit from investor excitement about the future of AI. Nvidia owns 1,960,784 shares of the company, which are valued at $268.9 million.
News in May that the company has plans to launch its first AI semiconductors in 2025 have also pushed Arm shares higher.
Meanwhile, SoundHound and Nano-X stocks are having their best years on record, jumping 119% and 23% in 2024, respectively. Nvidia owns 1,730,883 shares of SoundHound -- an AI voice technology company with a $1.6 billion market cap -- which are valued at $8.34 million. SoundHound has also benefited from the AI investing frenzy.
As for Nano-X, Nvidia owns 59,632 shares of the medical imaging systems developer, which are worth $483,019. Nano-X, which has a $468 million market cap, announced on Wednesday that it has launched an AI functionality into its Second Opinions online medical consultation, a platform that connects patients with radiologists for additional consultations on their medical diagnoses. The AI technology is intended to promote early detections of chronic conditions on chest and abdominal CT scans, according to a company news release.
Out of the four companies Nvidia invests in, the chip maker's largest stake is in Recursion Pharmaceuticals, owning 7,706,363 shares that are valued at $69.4 million. Recursion is a clinical-stage biotechnology company with a $2.1 billion market cap.
Unlike the other holdings, Recursion stock has dropped 13% to $8.61 this year -- and is on pace to have its worst year since 2022, according to Dow Jones Market Data. Recursion announced in July 2023 that Nvidia had invested in the company as they work toward developing drugs with the help of AI.
AI
